The first case involves a 54-year-old man who, about one month after starting semaglutide, experienced a marked decline in energy, motivation, fatigue, difficulty concentrating, and mood disturbances
Molecular rejuvenation: In animal studies, GLP-1 drugs have reversed many age-related changes at the molecular level, including improving the function of genes and proteins involved in cell repair, energy production, and metabolism
Side-effect management nausea on day 4 isn't a reason to stop
The 30-month stay locks in the generics first-to-file priority status and sets up the eventual litigation resolution (whether settlement, trial win, or loss)